Literature DB >> 22903674

Naturally occurring autoantibodies mediate ischemia/reperfusion-induced tissue injury.

Sherry D Fleming1.   

Abstract

Ischemia and reperfusion events within the heart and brain and similar trauma-induced ischemia/reperfusion events lead to significant morbidity and mortality. In the past two decades, an excessive innate immune response has been identified as the mediator of reperfusion-induced tissue damage. Recent evidence indicates that naturally occurring autoantibody (NAb) activation of complement is a major mechanism of injury due to ischemia/reperfusion. This chapter focuses on the antigens exposed by ischemia and recognized by NAbs, the mechanism of complement activation by damaging NAbs and the protective role of IVIG in ischemia/reperfusion-induced pathology.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22903674     DOI: 10.1007/978-1-4614-3461-0_13

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  5 in total

Review 1.  Targeting mechanisms at sites of complement activation for imaging and therapy.

Authors:  V Michael Holers
Journal:  Immunobiology       Date:  2015-04-30       Impact factor: 3.144

2.  Role of IgM and angiotensin II Type I receptor autoantibodies in local complement activation in placental ischemia-induced hypertension in the rat.

Authors:  Jean F Regal; Megan E Strehlke; Jenna M Peterson; Cameron R Wing; Jordan E Parker; Noel Fernando Nieto; Lynne T Bemis; Jeffrey S Gilbert; Sherry D Fleming
Journal:  Mol Immunol       Date:  2016-08-30       Impact factor: 4.407

3.  Natural IgM antibodies that bind neoepitopes exposed as a result of spinal cord injury , drive secondary injury by activating complement.

Authors:  Aarti Narang; Fei Qiao; Carl Atkinson; Hong Zhu; Xiaofeng Yang; Liudmila Kulik; V Michael Holers; Stephen Tomlinson
Journal:  J Neuroinflammation       Date:  2017-06-19       Impact factor: 8.322

4.  Beta2 glycoprotein I-derived therapeutic peptides induce sFlt-1 secretion to reduce melanoma vascularity and growth.

Authors:  Haley Smalley; Jennifer M Rowe; Fernando Nieto; Jazmin Zeledon; Kellyn Pollard; John M Tomich; Sherry D Fleming
Journal:  Cancer Lett       Date:  2020-09-04       Impact factor: 8.679

5.  Deficiency of complement receptors CR2/CR1 in Cr2⁻/⁻ mice reduces the extent of secondary brain damage after closed head injury.

Authors:  Miriam D Neher; Megan C Rich; Chesleigh N Keene; Sebastian Weckbach; Ashley L Bolden; Justin T Losacco; Jenée Patane; Michael A Flierl; Liudmila Kulik; V Michael Holers; Philip F Stahel
Journal:  J Neuroinflammation       Date:  2014-05-24       Impact factor: 8.322

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.